Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta‐analysis-Reference-Cited by-同舟云学术

Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta‐analysis

Published:2021-12-08 Issue:2 Volume:26 Page:540-547
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Tian Qi¹^ORCID,Guo Keyu¹,Deng Jiayi²,Zhong Yanjun²^ORCID,Yang Lin¹^ORCID

Affiliation:

1. National Clinical Research Center for Metabolic Diseases Key Laboratory of Diabetes Immunology, Ministry of Education Department of Metabolism and EndocrinologyThe Second Xiangya Hospital of Central South University Changsha HunanChina

2. ICU CenterThe Second Xiangya Hospital of Central South University Changsha Hunan China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17115

Reference41 articles.

1. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug

2. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

3. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

4. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

5. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

2. The effect of sodium-glucose transporter 2 inhibitors on stroke in patients with type 2 diabetes: A meta-analysis;Journal of Stroke and Cerebrovascular Diseases;2024-08

3. Association Between SGLT2 Inhibitor Use and Change in Hemoglobin Among Adults with Diabetes: A Nationwide Cohort Study;Journal of General Internal Medicine;2024-04-09

4. Erythrocytosis and CKD: A Review;American Journal of Kidney Diseases;2024-04

5. SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback;Kidney360;2024-03-25